Survanta 25 Mg Injection

Survanta 25 Mg Injection 4 ml is a life-saving medication specifically formulated for premature infants who are at risk of or suffering from Respiratory Distress Syndrome (RDS). RDS is a condition where the lungs of premature babies are not fully developed, leading to a deficiency in surfactant, a substance that helps keep the air sacs in the lungs open.

Strength25 mg/mL
Packaging size8ml
Brand NameSurvant
Shelf Life12 month
FormInjection
Packaging TypeBox
Country of originMade in India
CompostionBeractant
TreatmentTreatment of RDS
SKU: 00445 Categories: ,

Description

Survanta 25 Mg Injection 4 ml is a life-saving medication specifically formulated for premature infants who are at risk of or suffering from Respiratory Distress Syndrome (RDS). RDS is a condition where the lungs of premature babies are not fully developed, leading to a deficiency in surfactant, a substance that helps keep the air sacs in the lungs open.

The active ingredient in Survanta is beractant, a natural bovine (cow) lung extract containing phospholipids, neutral lipids, fatty acids, and surfactant-associated proteins. This composition closely mimics natural human surfactant, enabling it to effectively reduce surface tension in the lungs, improving oxygen exchange and lung function.

Administered directly into the infant’s trachea via an endotracheal tube, Survanta  works rapidly to coat the inner lining of the lungs. This helps to prevent the air sacs from collapsing after each breath, making it easier for the baby to breathe and reducing the effort required for respiration. By improving lung function, Survanta significantly increases the chances of survival and reduces the risk of long-term complications associated with RDS.

Survanta is indicated for the prevention and treatment (‘rescue’) of RDS in premature infants. Dosage and administration are carefully determined by medical professionals based on the infant’s weight and clinical condition. It is crucial that Survanta is administered by trained personnel in a neonatal intensive care unit (NICU) equipped to handle potential complications.

Potential side effects of Survanta include transient oxygen desaturation, bradycardia (slow heart rate), and airway obstruction. These side effects are typically monitored and managed by the medical team. SURVANTA has dramatically improved the prognosis for premature infants with RDS, allowing them to breathe easier and thrive.

We have strong global networks in Africa, Europe, United Kingdom, United States, Chile, Peru, Ethiopia, Romania, China, Japan, Russia, Ukraine, Dubai, Unites Arab Emirates, Thailand, Vietnam, Middle East and South East Countries.

Explore more products Tablets & Capsules

Tablets & Capsules – GlobMedIndia

Additional information

Strength

25 mg/mL

Packaging size

8ml

Brand Name

Survant

Shelf Life

12 month

Form

Injection

Packaging Type

Box

Country of origin

Made in India

Compostion

Beractant

Treatment

Treatment of RDS

Reviews

There are no reviews yet.

Be the first to review “Survanta 25 Mg Injection”

Your email address will not be published. Required fields are marked *